Cytoprotection
The protection of cells from harmful agents or conditions. Cytoprotective mechanisms include maintaining membrane integrity, protecting mitochondrial function, and reducing oxidative stress. Elamipretide provides cytoprotection by stabilising cardiolipin in mitochondrial membranes for Barth syndrome.
Technical Context
Cytoprotective mechanisms include: maintenance of cell membrane integrity (through antioxidant defence, membrane repair mechanisms), mitochondrial protection (preserving electron transport chain function, preventing cytochrome c release), anti-apoptotic signalling (activating survival pathways like PI3K/Akt, inhibiting pro-apoptotic factors), reduction of oxidative stress (upregulating antioxidant enzymes — superoxide dismutase, catalase, glutathione peroxidase), and anti-inflammatory effects (reducing cytokine-mediated cell damage). Elamipretide's cytoprotective mechanism: it is a cell-permeable tetrapeptide (D-Arg-Dmt-Lys-Phe-NH2, where Dmt is 2',6'-dimethyltyrosine) that targets the inner mitochondrial membrane, binding to cardiolipin to stabilise cristae structure and optimise electron transport chain complex organisation, improving ATP production and reducing ROS generation. This mitochondrial targeting represents a novel cytoprotective strategy distinct from conventional antioxidant approaches.